Xeltis successfully passes evaluation phase for €10million investment from European Innovation Council
- Xeltis is one of only seven companies to successfully pass evaluation phase of EIC Strategic Technologies for Europe Platform (STEP) Scale Up call
- Funding to support commercialization of its groundbreaking bioresorbable vascular conduits
EINDHOVEN, The Netherlands, 8 April 2025 – Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces that it has successfully passed the evaluation phase of the 2025 European Innovation Council (‘EIC’) STEP Scale-Up call program, and is set to secure a €10 million equity investment from the EIC, subject to an award decision by the European Commission and to an EIC Fund Investment Committee decision.
